Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Journal of Molecular Medicine (Berlin, Germany)|May 29, 2004
Targeting multiple signal transduction pathways through inhibition of Hsp90Hong Zhang, Francis BurrowsCell Cycle (Georgetown, Tex.)|November 13, 2004
Hsp90 activation and cell cycle regulationFrancis Burrows, Hong Zhang, Adeela KamalCancers|November 13, 2021
Potential of Farnesyl Transferase Inhibitors in Combination Regimens in Squamous Cell CarcinomasLinda Kessler, Shivani Malik, Mollie Leoni, et al.Annals of the New York Academy of Sciences|May 22, 2007
Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stressPaul Workman, Francis Burrows, Len Neckers, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Potent activity of a novel dimeric heat shock protein 90 inhibitor against head and neck squamous cell carcinoma in vitro and in vivoXiaoying Yin, Hong Zhang, Francis Burrows, et al.BMC Pharmacology & Toxicology|June 18, 2013
Efficacy of RNA polymerase II inhibitors in targeting dormant leukaemia cellsMonica Pallis, Francis Burrows, Abigail Whittall, et al.British Journal of Haematology|September 1, 2012
The multi-kinase inhibitor TG02 overcomes signalling activation by survival factors to deplete MCL1 and XIAP and induce cell death in primary acute myeloid leukaemia cellsMonica Pallis, Amina Abdul-Aziz, Francis Burrows, et al.International Journal of Cancer|August 8, 2009
BIIB021, a novel Hsp90 inhibitor, sensitizes head and neck squamous cell carcinoma to radiotherapyXiaoying Yin, Hong Zhang, Karen Lundgren, et al.International Journal of Cancer|August 14, 2009
BIIB021, a synthetic Hsp90 inhibitor, has broad application against tumors with acquired multidrug resistanceHong Zhang, Laura Neely, Karen Lundgren, et al.Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|September 15, 2009
An investigation into the potential use of serum Hsp70 as a novel tumour biomarker for Hsp90 inhibitorsNaveen Dakappagari, Laura Neely, Shabnam Tangri, et al.Pageof 4